Grants and Contracts per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Residency, Northeast Louisiana University
1997
Doctor of Medicine, Tufts University
1972
Fingerprint
Dive into the research topics where Richard Greenberg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Covid 19: A Randomized, Double-blind, Phase 2 Study to Evaluate the Immunogenicity, Reactogenicity and Safety of Ad26.COV2.S Administered as Booster Vaccination in Adults 18 Years of Age and Older Who Have Previously Received Primary Vaccination with Ad26
Greenberg, R., Caudill, T. & Simmons, C.
Janssen Vaccines and Prevention BV
7/26/21 → 6/28/23
Project: Research project
-
Covid 19: A Phase 2/3, Two-Part, Open-Label, Dose-Escalation, Age De-escalation and Randomized, Oberver-Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA-1273 SARS-CoV-2 Vaccine
Fuchs, G., Bauer, J., Desai, N., Greenberg, R., Robbins, S., Simmons, C. & Wurth, M.
6/16/21 → 1/7/24
Project: Research project
-
Covid 19: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older
Greenberg, R., Caudill, T., Englert, B., Kern, P. & Simmons, C.
Janssen Vaccines and Prevention BV
2/5/21 → 11/2/23
Project: Research project
-
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study
Thompson, G. R., Garcia-Diaz, J., Miceli, M. H., Nguyen, M. H., Ostrosky-Zeichner, L., Young, J. A. H., Fisher, C. E., Clark, N. M., Greenberg, R. N., Spec, A., Kovanda, L., Croos-Dabrera, R. & Kontoyiannis, D. P., Feb 2022, In: Mycoses. 65, 2, p. 186-198 13 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Erratum: Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis (Journal of Hepatology (2019) 70(5) (930–940), (S0168827819300297), (10.1016/j.jhep.2018.12.038))
Gwag, T., Meng, Z., Sui, Y., Helsley, R. N., Park, S. H., Wang, S., Greenberg, R. N. & Zhou, C., Apr 2021, In: Journal of Hepatology. 74, 4, p. 1003-1004 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
A Paradigm Shift Has Begun: Diarrheal Disease Takes a New Form
Ribes, J. A., Arora, V. & Greenberg, R. N., Oct 15 2019, In: Clinical Infectious Diseases. 69, 9, p. 1553-1554 2 p.Research output: Contribution to journal › Comment/debate
-
Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
Gwag, T., Meng, Z., Sui, Y., Helsley, R. N., Park, S. H., Wang, S., Greenberg, R. N. & Zhou, C., May 2019, In: Journal of Hepatology. 70, 5, p. 930-940 11 p.Research output: Contribution to journal › Article › peer-review
38 Scopus citations -
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
Schmoele-Thoma, B., van Cleeff, M., Greenberg, R. N., Gurtman, A., Jones, T. R., Sundaraiyer, V., Gruber, W. C. & Scott, D. A., Mar 4 2019, In: Human Vaccines and Immunotherapeutics. 15, 3, p. 575-583 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations